BBS-Bioactive Bone Substitutes Oyj (BONEH) — Cash Flow-to-Debt Ratio
BBS-Bioactive Bone Substitutes Oyj (BONEH) has a Cash Flow-to-Debt Ratio of -0.28x as of June 2024, meaning its operating cash flow of €-1.58 Million could theoretically repay 0% of its total liabilities (€5.58 Million) in one year. See BBS-Bioactive Bone Substitutes Oyj (BONEH) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BBS-Bioactive Bone Substitutes Oyj Cash Flow-to-Debt Ratio (2015–2023)
Historical debt coverage capacity for BBS-Bioactive Bone Substitutes Oyj across 9 annual periods. Also explore BBS-Bioactive Bone Substitutes Oyj equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BBS-Bioactive Bone Substitutes Oyj (2015–2023)
Year-by-year debt coverage analysis for BBS-Bioactive Bone Substitutes Oyj. For market capitalisation and broader financial context, see BBS-Bioactive Bone Substitutes Oyj (BONEH) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.53x | €-2.92 Million | €5.50 Million | ▼ -21.0% |
| 2022 | -0.44x | €-2.82 Million | €6.42 Million | ▼ -19.7% |
| 2021 | -0.37x | €-2.52 Million | €6.87 Million | ▼ -0.2% |
| 2020 | -0.37x | €-2.42 Million | €6.61 Million | ▼ -71.2% |
| 2019 | -0.21x | €-1.44 Million | €6.75 Million | ▲ +15.3% |
| 2018 | -0.25x | €-1.70 Million | €6.74 Million | ▼ -101.5% |
| 2017 | -0.13x | €-1.08 Million | €8.60 Million | ▼ -88.2% |
| 2016 | -0.07x | €-546.00K | €8.21 Million | ▼ -23.6% |
| 2015 | -0.05x | €-430.00K | €7.99 Million | — |